SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Emisphere
EMIS 10.04-0.2%Feb 9 2:51 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: L. Remmel who started this subject1/27/2001 8:14:12 PM
From: hmpa   of 272
 
Timeline, according to Adams and Harkness (credit to Yahoo poster Dsos5):
messages.yahoo.com

<<This information comes from a Adams, Harkness & Hill report dated 24-Jan-2001
Emisphere Milestone Update:

1. Lilly to begin Phase I trials with oral PTH (Forteo) - First half 2001

2. Finalize DuPont (or other) marketing partnership - First half 2001

3. Publish Phase II liquid SNAC/heparin results - First half 2001

4. Results of the first phase III liquid SNAC/heparin trial in orthopedic patients - Mid-year 2001

5. Novartis to begin Phase II trials with oral Calcitonin - Mid-year 2001

6. Initiate Phase I clinical trials for a Insulin solid oral dosage formulation - Q4 2001

7. Begin phase I trials with oral hGH - Second half 2001

8. File NDA for liquid SNAC/heparin - Year end 2001

9. Begin second liquid SNAC/heparin Phase III trial to prevent DVT - 2001

10. FDA approval of liquid SNAC/heparin (asumes 12 month review) - Year end 2002

11. FDA approval of Calcitonin - 2004
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News